Your browser doesn't support javascript.
loading
History of heart failure and chronic kidney disease and risk of all-cause death after COVID-19 during the first three waves of the pandemic in comparison with influenza outbreaks in Sweden: a registry-based, retrospective, case-control study.
Ritsinger, Viveca; Bodegård, Johan; Kristofi, Robin; Thuresson, Marcus; Nathanson, David; Nyström, Thomas; Eriksson, Jan; Norhammar, Anna.
Afiliação
  • Ritsinger V; Cardiology Unit, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden viveca.ritsinger@ki.se.
  • Bodegård J; Department of Research and Development, Region Kronoberg, Vaxjo, Sweden.
  • Kristofi R; Cardiovascular, Renal and Metabolism, Medical Department, BioPharmaceuticals, AstraZeneca Nordic, Oslo, Norway.
  • Thuresson M; Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.
  • Nathanson D; Statisticon AB, Uppsala, Sweden.
  • Nyström T; Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.
  • Eriksson J; Department of Clinical Science and Education, Karolinska Institute, Södersjukhuset, Stockholm, Sweden.
  • Norhammar A; Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.
BMJ Open ; 13(4): e069037, 2023 04 28.
Article em En | MEDLINE | ID: mdl-37117003
ABSTRACT

OBJECTIVES:

To explore how cardiorenal disease (CRD; heart failure and/or chronic kidney disease) impacted mortality in men and women hospitalised for COVID-19 during the first three waves of the pandemic in Sweden in comparison to previous influenza outbreaks.

DESIGN:

A registry-based, retrospective, case-control study.

SETTING:

Hospital care in Sweden.

PARTICIPANTS:

All patients in Sweden with a main hospital diagnosis of COVID-19 (January 2020-September 2021) or influenza (January 2015-December 2019) with previous CRD were identified in registries and compared with a reference group free from CRD but with COVID-19 or influenza. PRIMARY OUTCOME

MEASURE:

Associated risk of all-cause death during the first year was analysed using adjusted Cox proportional hazards models.

RESULTS:

In COVID-19 patients with and without prior history of CRD (n=44 866), mean age was 79.8 years (SD 11.8) and 43% were women. In influenza patients (n=8897), mean age was 80.6 years (SD 11.5) and 45% were women. COVID-19 versus influenza was associated with higher mortality risk during the first two COVID-19 waves (HR 1.53; 95% CI 1.45 to 1.62, p<0.001 and HR 1.52; 95% CI 1.44 to 1.61, p<0.001), but not in the third wave (HR 1.07; 95% CI 0.99 to 1.14, p=0.072). CRD was an independent risk factor for all-cause death after COVID-19 in men and women (men 1.37; 95% CI 1.31 to 1.44, p<0.001; women 1.46; 95% CI 1.38 to 1.54, p<0.001). At ages <70 years, women with CRD had a similar mortality rate to men with CRD, while at ages ≥70 years, the mortality rate was higher in men.

CONCLUSIONS:

Outcome after COVID-19 is worse if CRD is present. In women at ages <70 years, the presence of CRD attenuates the protective effect of female sex. COVID-19 was associated with higher mortality risk than influenza during the first two pandemic waves.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Influenza Humana / COVID-19 / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Influenza Humana / COVID-19 / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia